Fuda Cancer Hospital Doctors: Specialists, Procedures & Case Fit
Choosing a FUDA doctor should start with the cancer type, stage, treatment goal and procedure question — not with a single name. FUDA’s current doctor directory includes surgical oncology, minimally invasive ablation, medical oncology, head-and-neck oncology, radiology and international-patient roles.
Quick answer: FUDA’s current treatment directory lists Prof. Niu Lizhi as Vice President / Chief Surgeon with a published focus
on minimally invasive cryosurgery; Dr. Liu Shupeng with experience across cryoablation, microwave ablation, RFA,
brachytherapy and IRE/NanoKnife; Prof. Zeng Zongyuan in head-and-neck oncology; and additional physicians across
multidisciplinary oncology, surgery, radiology and international consultation. Doctor availability and assignment
for an overseas patient still need case-specific confirmation.
✓ No universal “best doctor” claim
✓ Official FUDA profiles separated from independent evidence
✓ Current availability must be confirmed
✓ Medical records come before doctor routing
FUDA Doctor Map: Who Is Linked to Which Clinical Area?
| Doctor | FUDA-published role | Published clinical focus | Best question to route |
|---|---|---|---|
| Prof. Niu Lizhi | Vice President; Chief Surgeon; Oncology | Minimally invasive cryosurgery; solid tumors including pancreatic, liver, lung and renal cancers | Whether a technically complex ablation / cryo / IRE question deserves specialist review |
| Dr. Liu Shupeng | Attending Physician; Deputy Director, Medical Office V | Cryoablation, microwave ablation, RFA, brachytherapy, IRE; multiple common solid tumors | Interventional-oncology or multi-ablation treatment questions |
| Prof. Zeng Zongyuan | Chief Specialist; Chief Physician; Head & Neck Cancer Center | Head-and-neck tumors; FUDA profile highlights laryngeal, thyroid, parotid and cervical lesions | Head-and-neck oncology / surgical-specialist review |
| Dr. Wang Feng | Associate Chief Physician; Deputy Director, Medical Office II | Surgical oncology; breast, gastrointestinal and head-and-neck tumors; chemotherapy and targeted therapy | Multimodality surgical-oncology case review |
| Dr. Wang Zijun | Attending Doctor, Medical Office III | Medical oncology and radiotherapy; multidisciplinary treatment of solid tumors | Radiotherapy + systemic-treatment sequencing questions |
| Dr. Long Xin’an | Attending Physician; Secretary, Medical Office I | Multidisciplinary oncology; needle biopsy and cryosurgery experience | General complex-oncology / diagnostic-procedure routing |
| Dr. Li Zhonghai | M.D.; Director of Radiology Center | Radiology / imaging support | Image review and image-guided procedure planning questions |
| Dr. Anup Aboti | Medical Oncology Consultant | FUDA describes international oncology consultation, palliative care and pain-management experience | International consultation and supportive-care questions |
This is a case-routing map, not a ranking. Titles and specialties above come from FUDA’s published doctor directory and individual profiles; current clinic schedules and the doctor who will actually review an overseas case must be confirmed.
Prof. Niu Lizhi: Cryoablation, IRE and Complex Local Treatment Questions
Vice President · Chief Surgeon · Oncology
FUDA’s current treatment directory lists Prof. Niu Lizhi as Vice President and Chief Surgeon, while some FUDA news/profile pages use different executive-title wording. His consistently published clinical focus is minimally invasive cryosurgery for solid tumors, including pancreatic, liver, lung, renal, thyroid and peritoneal cancers.
FUDA-affiliated cryo / IRE research
PubMed-indexed FUDA work includes Niu as an author on liver cryoablation, lung cryoablation and pancreatic IRE publications. This supports a documented research footprint; it does not prove that ablation is the right treatment for every patient or superior to standard therapy.
Claims need separation. FUDA’s biography contains promotional statements about procedure volume and
global experience. ParkMega does not repeat those statements as independently verified facts. FUDA pages also use
inconsistent executive-title wording for Niu (the current treatment directory lists Vice President / Chief Surgeon,
while some 2026 news pages call him President), so we rely on the stable clinical specialty rather than an administrative title.
For a patient, the useful question is whether the tumor location, stage, prior treatment and current standard options make an ablation review reasonable.
Dr. Liu Shupeng: Interventional Oncology and Multi-Ablation Experience
FUDA’s profile lists Dr. Liu Shupeng as an attending physician and Deputy Director of Medical Office V, with published
experience in brachytherapy, cryosurgical ablation, microwave ablation, radiofrequency ablation and irreversible
electroporation (NanoKnife/IRE).
Ground-glass lung nodules
Liu is first author of a 2019 pilot study on CT-guided cryoablation for lung ground-glass opacity and a 2022 retrospective study of 50 patients with GGO-dominant lung nodules. Those studies are useful evidence of procedure experience, but they are not randomized comparisons against surgery.
IRE + chemotherapy
Liu is also first author of a 2019 prospective cohort study of IRE combined with chemotherapy for unresectable pancreatic carcinoma. A cohort study can inform feasibility and outcomes, but it should not be treated as definitive proof that IRE improves survival over modern standard care.
FUDA also reported Dr. Liu presenting on cryoablation combined with PD-1 inhibition and chemotherapy at the January 2026 Saudi Interventional Radiology Society congress. That is a current academic-activity signal from the hospital, not independent efficacy evidence.
Prof. Zeng Zongyuan: Head-and-Neck Oncology
Head & Neck Cancer Center
FUDA lists Prof. Zeng Zongyuan as Chief Specialist, Chief Physician and Director of its Head & Neck Cancer Center. His hospital profile describes decades of work in head-and-neck oncology and prior senior roles at Sun Yat-sen University cancer services.
When this profile may matter
A head-and-neck cancer patient should still route by exact site, pathology, stage, resectability, prior radiation and reconstruction needs. A famous name alone does not answer whether FUDA is the right center for that particular case.
Other FUDA Doctors Relevant to International Case Routing
Dr. Wang Feng
FUDA describes surgical-oncology experience across breast, gastrointestinal and head-and-neck tumors, together with chemotherapy and targeted therapy.
Dr. Wang Zijun
His FUDA profile emphasizes individualized multidisciplinary plans, particularly coordination of radiotherapy and chemotherapy for solid tumors.
Dr. Long Xin’an
FUDA’s 2023 profile describes more than 10 years in oncology with needle-biopsy and cryosurgery experience and management of complex cases.
Dr. Li Zhonghai
The current FUDA directory lists Li Zhonghai as Director of the Radiology Center — relevant where image interpretation or image-guided treatment planning is central.
Dr. Anup Aboti
FUDA lists him as a Medical Oncology Consultant and describes oncology counselling, palliative-care and pain-management experience.
Dr. Michael Litvinov — verify current availability
FUDA has a 2019 profile describing Dr. Michael Litvinov as a Russian-speaking international-clinic oncologist. Because that profile is old, ParkMega does not assume he is currently available. Confirm directly before routing a patient by language.
Doctor Name or Procedure First? Use the Clinical Question
| If your main question is… | FUDA profile to review | What still needs confirmation |
|---|---|---|
| Cryoablation for a solid tumor | Niu Lizhi / Liu Shupeng | Tumor size, location, stage, procedural goal, competing standard treatments and who will perform the procedure |
| NanoKnife / IRE for pancreas or another difficult location | Niu Lizhi / Liu Shupeng | Anatomy, vascular involvement, resectability, systemic-treatment plan, contraindications and whether FUDA accepts the case |
| Head-and-neck cancer | Zeng Zongyuan | Exact site, pathology, stage, surgery vs radiation strategy, reconstruction and current appointment availability |
| Surgical oncology / multimodality solid-tumor plan | Wang Feng / relevant disease team | Whether FUDA’s surgical team or another high-volume academic center is a better fit for the specific operation |
| Radiotherapy plus systemic treatment | Wang Zijun / relevant MDT | Radiation technique, prior radiation dose, systemic regimen, sequencing and multidisciplinary review |
| Image-guided procedure planning | Radiology + treating oncology team | DICOM imaging, lesion accessibility, safe needle path and who is responsible for procedural planning |
How Strong Is the Evidence Behind FUDA’s Doctor Profiles?
Official FUDA directory
Useful for published job titles, specialty descriptions and whether a clinician is currently displayed by the hospital.
PubMed-indexed papers
Useful for confirming authorship, hospital affiliation, study design and the clinical questions a team has actually studied.
Current activity, but provider-reported
Conference presentations and hospital biographies can show current activity but are not independent evidence of treatment superiority or outcomes.
Cannot be inferred from a profile
The doctor who is suitable for one patient depends on diagnosis, stage, prior therapy, anatomy, performance status, treatment goal and availability.
What to Send if You Want FUDA to Match a Doctor to Your Case
Core medical file
- Pathology report and immunohistochemistry
- Current cancer stage and metastatic sites
- Recent CT / MRI / PET-CT reports and DICOM files when available
- Previous surgery, radiation and systemic-treatment history
- Relevant biomarkers / molecular testing
- Current symptoms, medicines and performance status
Ask one precise doctor question
- Is cryoablation technically relevant?
- Is IRE / NanoKnife being considered, and why?
- Does the case need head-and-neck surgery expertise?
- Is radiation being considered after prior radiation?
- Which department and doctor would actually review the file?
- Can that doctor communicate directly in English, or will an interpreter be used?
Can You Request a Specific FUDA Doctor as an International Patient?
You can ask FUDA whether a named doctor can review the case, but a published profile does not guarantee availability,
direct consultation or that the named doctor will perform a procedure. The hospital may route the file to another
department or multidisciplinary team after reviewing the diagnosis and records.
If direct English communication with the treating doctor matters, ask that explicitly. Interpreter support and physician-level English communication are separate questions. For the wider admission, visa and travel workflow, see Fuda Cancer Hospital for International Patients.
2026 Activity Signals: What Is Current and What Is Marketing?
Guangdong–Hong Kong cryoablation exchange
FUDA reported an expert exchange where visitors observed image-guided cryoablation for liver, lung, kidney and adrenal tumors. Niu Lizhi participated in the academic discussion. This is evidence of current program activity, not comparative outcomes.
Liu Shupeng at SIRS
FUDA reported Liu Shupeng presenting on cryoablation combined with PD-1 inhibitors and chemotherapy for advanced lung cancer. Conference presentation is useful for freshness, but treatment-effect claims still need peer-reviewed context.
When Should You Compare FUDA With Another Cancer Center?
Major surgery is the central question
Compare surgeon and hospital volume, disease-specific center experience and multidisciplinary support rather than assuming a minimally invasive hospital is automatically the best surgical choice.
The treatment is highly disease-specific
Some cancers may be better served by a national academic cancer center with a larger disease-specific program, even if FUDA offers a technically interesting procedure.
The recommendation conflicts with standard care
Ask for the rationale, evidence and alternatives. A procedure should not replace established systemic treatment, surgery or radiation without a case-specific medical reason.
You cannot verify who will actually treat you
Before travel, confirm the responsible department, named reviewing physician where possible, procedure operator and whether the plan is provisional.
How ParkMega Uses the Doctor Information
Start with case fit, then doctor fit
Send the pathology, stage, imaging and treatment history. We can structure the question for FUDA around the relevant department or published doctor profile and identify what still needs direct hospital confirmation before travel.
Related FUDA and China Cancer Guides
Frequently Asked Questions
Direct answers about FUDA doctors, specialties, availability, evidence and international-patient routing.
Who is Prof. Niu Lizhi at Fuda Cancer Hospital?
FUDA’s current treatment directory lists Prof. Niu Lizhi as Vice President, Chief Surgeon and an oncology physician focused on minimally invasive cryosurgery. Some other FUDA pages use different executive-title wording, so the exact administrative title should be reconfirmed if material to the patient. FUDA-affiliated PubMed publications also document his authorship in cryoablation and IRE research. A profile or publication history does not by itself determine whether a procedure is appropriate for a specific patient.
Which FUDA doctor is associated with cryoablation?
FUDA’s profiles most clearly connect Prof. Niu Lizhi and Dr. Liu Shupeng with cryoablation. Liu’s profile also lists microwave ablation, radiofrequency ablation, brachytherapy and IRE. The actual treating doctor and technical suitability must be confirmed after the hospital reviews the case.
Which FUDA doctor is associated with NanoKnife or IRE?
FUDA’s published material links Niu Lizhi and Liu Shupeng with irreversible electroporation, also called NanoKnife. For pancreatic or anatomically complex tumors, ask whether IRE is being considered, why, what alternatives exist and who would perform the procedure.
Which FUDA doctor treats head-and-neck cancer?
FUDA lists Prof. Zeng Zongyuan as Chief Specialist, Chief Physician and Director of its Head & Neck Cancer Center. A head-and-neck case should still be routed by exact tumor site, pathology, stage, previous radiation and surgical/reconstruction requirements.
Can an international patient choose a specific FUDA doctor?
You can request review by a named doctor, but a published profile does not guarantee availability, direct consultation or that the named doctor will perform treatment. FUDA may route the file to another specialist or multidisciplinary team after reviewing the records.
Do FUDA doctors speak English directly?
FUDA publishes international-patient and interpreter services, but interpreter availability is not the same as the treating doctor communicating directly in English. If direct doctor-patient communication in English matters, ask FUDA to confirm it for the specific doctor and appointment.
Does FUDA have a Russian-speaking doctor?
FUDA has a 2019 profile for Dr. Michael Litvinov describing a Russian-speaking international-clinic role. Because the profile is old, current availability should be confirmed directly before routing a Russian-speaking patient to him.
How current are FUDA doctor titles on the website?
ParkMega uses FUDA’s current doctor directory and published profiles, but hospital websites can lag staffing changes. Titles, appointment availability, department assignment and who will actually review an international case should be reconfirmed before travel.
What records should I send for FUDA doctor matching?
Send pathology, cancer stage, recent CT/MRI/PET-CT reports and imaging files when available, previous surgery/radiation/systemic-treatment history, relevant biomarkers, current medicines and the precise clinical question you want answered.
Are FUDA doctor biographies independent evidence?
No. Doctor biographies and hospital news are provider-published sources. They are useful for role, specialty and current-activity signals, but promotional claims about experience or outcomes should be separated from peer-reviewed publications, registries and independent clinical evidence.
Does a PubMed paper prove that the doctor or treatment is best?
No. A PubMed-indexed paper can confirm authorship, affiliation, study design and research experience. It does not establish that one doctor is universally better or that the studied treatment is appropriate for every patient. Study design, sample size, comparison group and current standard care still matter.
Should I compare a FUDA doctor with another China cancer center?
Yes when the case involves major surgery, a highly disease-specific program, a treatment recommendation that differs from standard care, or uncertainty about who will actually treat the patient. Compare the clinical team and hospital by the exact cancer and treatment question rather than by a universal ranking.
Sources and Evidence
- FUDA — Doctors directory. Current hospital-published roster and titles. Official directory.
- FUDA — Prof. Niu Lizhi. Published role, education and minimally invasive oncology focus. Official profile.
- FUDA — Dr. Liu Shupeng. Published role and ablation/interventional-oncology focus. Official profile.
- FUDA — Prof. Zeng Zongyuan. Head-and-neck oncology role. Official profile.
- FUDA — Dr. Long Xin’an. Multidisciplinary oncology, biopsy and cryosurgery profile. Official profile.
- FUDA — Dr. Wang Feng. Surgical-oncology profile. Official profile.
- FUDA — Dr. Wang Zijun. Medical-oncology / radiotherapy profile. Official profile.
- FUDA — Dr. Anup Aboti. International medical-oncology consultant profile. Official profile.
- FUDA — Dr. Michael Litvinov. Historical 2019 international-clinic profile; current availability not assumed. Official profile.
- PubMed PMID 35490929. Liu et al., CT-guided cryoablation for lung nodules mainly composed of ground-glass opacities; retrospective study. PubMed.
- PubMed PMID 30964113. Liu et al., 2019 pilot study of CT-guided cryoablation for lung ground-glass opacity. PubMed.
- PubMed PMID 30863100. Liu et al., prospective cohort of IRE plus chemotherapy for unresectable pancreatic carcinoma. PubMed.
- PubMed PMID 26355719. Niu, Li and Xu review of percutaneous cryoablation for liver cancer. PubMed.
- FUDA 2026 activity. Guangdong–Hong Kong cryoablation exchange and SIRS 2026 presentation are hospital-reported current-activity signals, not independent treatment-effect evidence. April 2026 exchange; January 2026 SIRS report.
Freshness note: doctor rosters, titles, clinic schedules and language availability can change. Verify the responsible doctor / department for the actual patient before travel or payment.
Medical note: This page maps published specialties and evidence. It does not diagnose cancer, recommend a doctor as universally superior, guarantee an appointment or determine treatment eligibility.
Send the Case Before Choosing a Doctor by Name
Pathology, stage, imaging and prior treatment tell us more than a biography. Use those records to identify the relevant FUDA department, ask whether a named doctor can review the case, and compare another Chinese center when the clinical question requires it.
✓ No “best doctor” marketing
✓ Official roles checked
✓ Research separated from biographies
✓ Availability confirmed case by case
Match your cancer case to a Fuda doctor or department
Send the diagnosis, stage, imaging and treatment history first. The goal is to identify the relevant specialty or published doctor profile and confirm who can actually review the case.